1. Home
  2. BMRN vs COO Comparison

BMRN vs COO Comparison

Compare BMRN & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$56.55

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Logo The Cooper Companies Inc.

COO

The Cooper Companies Inc.

HOLD

Current Price

$66.79

Market Cap

12.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMRN
COO
Founded
1996
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
12.2B
IPO Year
1999
1994

Fundamental Metrics

Financial Performance
Metric
BMRN
COO
Price
$56.55
$66.79
Analyst Decision
Buy
Buy
Analyst Count
18
11
Target Price
$88.22
$90.18
AVG Volume (30 Days)
2.3M
2.9M
Earning Date
05-04-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.54
0.27
Revenue
$1,313,646,000.00
$2,532,800,000.00
Revenue This Year
$15.02
$6.66
Revenue Next Year
$12.23
$5.18
P/E Ratio
$105.13
$102.03
Revenue Growth
17.62
18.41
52 Week Low
$49.26
$58.89
52 Week High
$66.28
$89.83

Technical Indicators

Market Signals
Indicator
BMRN
COO
Relative Strength Index (RSI) 57.06 66.96
Support Level $51.74 $64.19
Resistance Level $56.91 $70.01
Average True Range (ATR) 1.74 1.64
MACD 0.52 0.97
Stochastic Oscillator 84.40 92.92

Price Performance

Historical Comparison
BMRN
COO

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About COO The Cooper Companies Inc.

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

Share on Social Networks: